As a prominent player in ophthalmology, ThromboGenics is dedicated to the research and development of drugs that address unmet clinical needs. Our main focus is on providing disease-modifying treatments for conditions that affect the back of the eye.

As a science driven company we are committed to sharing our research by making it publicly available on scientific conferences and or peer-reviewed publications.

To view the latest abstracts, posters or publications, click here.